Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer.
暂无分享,去创建一个
M. Gnant | P. Dubsky | R. Jakesz | S. Taucher | S. Roka | D. Kandioler | Barbara Pichler-Gebhard | I. Agstner | M. Seifert | P. Sevelda
[1] H. Bloom,et al. Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.
[2] H. Honoré,et al. Breast cancer in young women. , 1979, British medical journal.
[3] N. Ghossein,et al. The outcome of treatment by tumorectory and radiotherapy of patients with operable breast cancer , 1981 .
[4] The outcome of treatment by tumorectomy and radiotherapy of patients with operable breast cancer. , 1981, International journal of radiation oncology, biology, physics.
[5] M. Schemper,et al. Simultaneous and Sequential Determinations of Steroid Hormone Receptors in Human Breast Cancer: Influence of Intervening Therapy , 1985, Annals of surgery.
[6] I Persson,et al. The relation between survival and age at diagnosis in breast cancer. , 1986, The New England journal of medicine.
[7] A. Luini,et al. Young Age is not an Ominous Prognostic Factor in Breast Cancer Patients , 1987, Tumori.
[8] J. Vilcoq,et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. , 1989, International journal of radiation oncology, biology, physics.
[9] M. Schemper,et al. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. , 1990, Cancer research.
[10] T. Tsangaris,et al. Breast cancer in women under 35 years of age. , 1991, American journal of surgery.
[11] B. Asselain,et al. Age as prognostic factor in premenopausal breast carcinoma , 1993, The Lancet.
[12] D. Neuberg,et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] D. Schultz,et al. The influence of young age on outcome in early stage breast cancer. , 1994, International journal of radiation oncology, biology, physics.
[14] J. Crowe,et al. Age does not predict breast cancer outcome. , 1994, Archives of surgery.
[15] D. Allred,et al. Breast cancer outcome and predictors of outcome: are there age differentials? , 1994, Journal of the National Cancer Institute. Monographs.
[16] J. Sariego,et al. Breast cancer in young patients. , 1995, American journal of surgery.
[17] L Piana,et al. Age as a prognostic factor in breast cancer: Relationship to pathologic and biologic features , 1995, International journal of cancer.
[18] R. Walker,et al. Breast carcinomas occurring in young women (< 35 years) are different. , 1996, British Journal of Cancer.
[19] M. Cobleigh,et al. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] J. Rodriguez-Sierra,et al. Younger women with breast carcinoma have a poorer prognosis than older women , 1996, Cancer.
[21] H. Carmalt,et al. Breast cancer in young women. , 2020, The Australian and New Zealand journal of surgery.
[22] I. Henderson,et al. Are breast cancers in young women qualitatively distinct? , 1997, The Lancet.
[23] [Neoadjuvant chemotherapy of patients with breast carcinoma]. , 1998, Zentralblatt fur Chirurgie.
[24] NEOADJUVANTE CHEMOTHERAPIE BEI PATIENTINNEN MIT MAMMAKARZINOM , 1998 .
[25] A. Magener,et al. Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy. , 1998, European Journal of Cancer.
[26] M. Schmid,et al. VERMEIDUNG VON KOMPLIKATIONEN BEI AKUTER NEKROTISIERENDER PANKREATITIS DURCH ANTIBIOTIKAPROPHYLAXE , 1998 .
[27] H. Samonigg,et al. [Therapy studies of the Austrian Breast Cancer Group (ABC)]. , 1998, Zentralblatt fur Chirurgie.
[28] S. Steinberg,et al. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation. , 1998, Human pathology.
[29] P. Borgen,et al. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. , 1998, Journal of the American College of Surgeons.
[30] A. Feldman,et al. Long‐term outcome in women less than 30 years of age with breast cancer , 1998, Journal of surgical oncology.
[31] E. Touboul,et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. , 1999, International journal of radiation oncology, biology, physics.
[32] M. Gnant,et al. Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5 , 1999 .
[33] M. Gnant,et al. Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] R. Gelber,et al. Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? , 2000, The Lancet.
[35] Mike Clarke,et al. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000 .
[36] P. Andersen,et al. Factors influencing the effect of age on prognosis in breast cancer: population based study , 2000, BMJ : British Medical Journal.
[37] Contemporary issues in the use of radiation therapy for early invasive breast cancer. , 2000, Surgical oncology clinics of North America.
[38] J. Vermorken. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000, The Lancet.
[39] Commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancer. , 2000, BMJ.
[40] M. J. van de Vijver,et al. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial , 2000, Cancer.
[41] M. J. van de Vijver,et al. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] I. Bleiweiss,et al. Stage 0 to stage III breast cancer in young women. , 2000, Journal of the American College of Surgeons.
[43] E. Yıldırım,et al. Prognostic significance of young age in breast cancer , 2000, Journal of surgical oncology.
[44] G Noël,et al. [Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials]. , 2001, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[45] S. Wingren,et al. C-erbB-2 overexpression and survival in early onset breast cancer , 2000, Breast Cancer Research and Treatment.
[46] T. Turpeenniemi‐Hujanen,et al. MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma , 1999, Breast Cancer Research and Treatment.
[47] T. Fukushima,et al. Role of age as a prognostic factor in breast cancer , 2004, Surgery Today.
[48] S. Shousha,et al. Breast carcinoma in women under the age of 50: Relationship between p53 immunostaining, tumour grade, and axillary lymph node status , 1998, Breast Cancer Research and Treatment.